Trude Andreassen1,2,3, Adriana Melnic4, Rejane Figueiredo5, Kåre Moen6, Ofelia Şuteu7,8, Florian Nicula8, Giske Ursin9,10,11, Elisabete Weiderpass9,5,12,13. 1. Cancer Registry of Norway, Institute of Population-Based Cancer Research, Majorstuen, Post-box 5213, 0304, Oslo, Norway. trude.andreassen@kreftregisteret.no. 2. Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. trude.andreassen@kreftregisteret.no. 3. Institute of Health and Society, University of Oslo, Oslo, Norway. trude.andreassen@kreftregisteret.no. 4. The Romanian Cancer Society, Cluj-Napoca, Romania. 5. Folkhälsan Research Center, Genetic Epidemiology Group, Helsinki, Finland. 6. Institute of Health and Society, University of Oslo, Oslo, Norway. 7. University of Medicine and Pharmacy, "Iuliu Haţieganu", Cluj-Napoca, Romania. 8. Institute of Oncology "Prof. Dr. Ion Chiricuţă" Cluj-Napoca (IOCN), Cluj-Napoca, Romania. 9. Cancer Registry of Norway, Institute of Population-Based Cancer Research, Majorstuen, Post-box 5213, 0304, Oslo, Norway. 10. Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. 11. Department of Preventive Medicine, University of Southern California, Los Angeles, CA, USA. 12. Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway. 13. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Abstract
OBJECTIVES: Romania has Europe's highest incidence and mortality rates of cervical cancer. Participation in the national cervical cancer-screening programme is low, especially among minority Roma women. METHODS: We conducted a cross-sectional study, using a structured questionnaire aiming to quantify reasons for screening attendance among women in North-Western region of Romania. RESULTS: 980 women were enrolled in this study. Data were analysed using logistic regression, estimating odds ratios (OR) and 95% confidence intervals (CI). This study revealed that Roma women (46%) attended screening less frequently that non-Roma women (63%),; however, ethnicity in itself was not associated with screening attendance. Instead we found that attendance to the cervical cancer screening programme was determined by having ever heard about a screening opportunity (OR 5.90, 95% CI 3.76-9.27) and having three or more sex partners (OR 5.99, 95% CI 1.71-21.04). CONCLUSIONS: We concluded that information about the screening programme's existence and its rationale does not reach the women targeted for screening sufficiently and argue that a process of user involvement aiming to build contact, interaction and cooperation between the programme and its potential participants is warranted.
OBJECTIVES: Romania has Europe's highest incidence and mortality rates of cervical cancer. Participation in the national cervical cancer-screening programme is low, especially among minority Romawomen. METHODS: We conducted a cross-sectional study, using a structured questionnaire aiming to quantify reasons for screening attendance among women in North-Western region of Romania. RESULTS: 980 women were enrolled in this study. Data were analysed using logistic regression, estimating odds ratios (OR) and 95% confidence intervals (CI). This study revealed that Roma women (46%) attended screening less frequently that non-Roma women (63%),; however, ethnicity in itself was not associated with screening attendance. Instead we found that attendance to the cervical cancer screening programme was determined by having ever heard about a screening opportunity (OR 5.90, 95% CI 3.76-9.27) and having three or more sex partners (OR 5.99, 95% CI 1.71-21.04). CONCLUSIONS: We concluded that information about the screening programme's existence and its rationale does not reach the women targeted for screening sufficiently and argue that a process of user involvement aiming to build contact, interaction and cooperation between the programme and its potential participants is warranted.
Entities:
Keywords:
Access to health; Cervical cancer screening attendance; Discrimination; Health insurance; Minority Roma women; Odds ratio
Authors: Demetra Socolov; R Socolov; Ivona Aughelache Lupascu; V Rugina; O Gabia; Daniela Mihaela Garauleanu; A Carauleanu Journal: Rev Med Chir Soc Med Nat Iasi Date: 2016 Apr-Jun
Authors: Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray Journal: Int J Cancer Date: 2014-10-09 Impact factor: 7.396
Authors: Amanda J Chorley; Yasemin Hirst; Charlotte Vrinten; Christian von Wagner; Jane Wardle; Jo Waller Journal: J Med Screen Date: 2017-05-22 Impact factor: 2.136
Authors: Marisa Usera-Clavero; Diana Gil-González; Daniel La Parra-Casado; Carmen Vives-Cases; Pilar Carrasco-Garrido; Pablo Caballero Journal: Int J Public Health Date: 2020-01-14 Impact factor: 3.380
Authors: Anna Gottschlich; Pamela Ochoa; Alvaro Rivera-Andrade; Christian S Alvarez; Carlos Mendoza Montano; Claudia Camel; Rafael Meza Journal: Int J Public Health Date: 2019-12-14 Impact factor: 3.380